The medicine list for a laboratory test is a product-specific record with timing. "I take vitamins" is too broad. A cabinet photograph without the products actually used is too broad in a different way. The record should say what was taken, in what form, on the usual schedule, and when it was last used before the sample.
It is not a plan for independently stopping, skipping, doubling, or rescheduling anything.
Capture what is actually used
Start with the containers, pharmacy list, portal list, and products kept in more than one place. Include:
- prescription medicines;
- nonprescription pain, allergy, stomach, sleep, cold, or other products;
- vitamins, minerals, botanicals, amino acids, and other dietary supplements;
- combination products whose front label does not reveal every ingredient;
- powders, gummies, liquids, energy or wellness products used as supplements;
- injections, inhalers, patches, drops, and creams when they are part of the current routine; and
- a recently stopped product if its timing may be relevant to the ordered test.
This does not mean every product affects every laboratory result. It means the laboratory and ordering team need an accurate inventory before they can decide what matters.
The NIH Office of Dietary Supplements record offers a useful model: record the product, amount, schedule, start or stop dates, purpose, and the person responsible for its use. For a lab appointment, add route and last-use time.
Build the list from labels, not memory
Use one row per product:
| Field | What to record |
|---|---|
| Product | Exact label or prescription name |
| Active ingredients | All listed ingredients in a combination product |
| Form and route | Tablet by mouth, skin cream, injection, inhaler, or other actual form |
| Label strength or amount | Copy what the current container says; do not estimate |
| Usual schedule | The routine as actually followed |
| Last used | Date and clock time before collection |
| Recent change | Started, stopped, missed, or changed, with date if known |
| Source | Current bottle, pharmacy record, portal, or "uncertain" |
| Responsible contact | Prescriber, clinic, or other contact shown in the record |
If two sources disagree, do not silently merge them. Write "bottle says..." and "portal says..." and flag the mismatch. A pharmacy list can contain an old prescription; a bottle can remain in the cabinet after the plan changed. Reconciliation means exposing the conflict so the responsible team can resolve it.
Separate two kinds of relevance
A product can matter in at least two different ways. It may affect the body process being measured, or an ingredient may interfere with the measurement method itself. A person looking at the number generally cannot determine which mechanism applies.
Biotin is a well-documented example of analytical interference. The FDA guidance on biotin interference explains that some in-vitro diagnostic systems are susceptible and that interference can move results in different directions depending on the assay design. That does not mean every supplement contains biotin, every assay uses a susceptible design, or a person can correct a result by knowing the product amount.
The useful handoff names the product and ingredient, then lets the laboratory identify the method and its limitations. If a report seems inconsistent with other information, ask whether the method used has a known interference relevant to a documented product. Avoid announcing that a supplement "caused" the result.
Do not create your own hold instruction
MedlinePlus laboratory-preparation guidance says to tell the provider or laboratory professional about medicines, vitamins, and supplements, and not to stop medicines unless the provider gives that direction. This boundary matters. A general article cannot account for why a product is used, the consequences of interruption, or the protocol for a particular test.
If the written instructions say to change a medicine or supplement, verify these details with the ordering team:
- Which exact product and formulation does the instruction mean?
- Is the change required for every test on the order or one specific measurement?
- What is the last-use time specified by the responsible clinician or test protocol?
- What should happen if the product was already taken?
- When and under whose direction should the usual schedule resume?
Record the answer and its source. Do not infer a hold duration from an online discussion or from instructions for a different test.
If preparation instructions conflict with each other or with a safety-critical routine, contact the ordering team rather than choosing one yourself. For urgent testing, disclose the product use without delaying care to create a preferred interval.
Add timing only after the inventory is accurate
Timing gives the list a relationship to the specimen. Use the collection site's time zone and distinguish scheduled time, check-in time, and actual sample time. "Taken this morning" becomes more useful as "usual product taken at 6:45 a.m.; sample collected at 9:10 a.m."
If the time is uncertain, use a truthful range or write "time unknown." Avoid reconstructing a minute from a phone notification unless it actually records use.
A worked reconciliation example
Suppose a portal list shows "daily multivitamin," the bottle says the product has several vitamins including biotin, and the person also uses a hair-and-nail gummy stored at work. The portal has no gummy entry. The wrong response is to choose one product as the "real" supplement or decide that all testing is compromised.
A useful record would list both exact products, copy both ingredient panels, mark the gummy's amount and last-use time from the best available evidence, and note that it is absent from the portal. The ordering office or laboratory can then decide whether either product is relevant to the exact assays ordered.
The site's guide to the complete thyroid picture shows why method and clinical context matter when related results are reviewed together. The guide to cortisol sample types shows why timing and specimen type also belong with the result. Neither guide supplies a universal medicine-change rule.
Send a compact pre-test handoff
A useful message can fit in five lines:
Test and collection: exact order, date, and site
Current products: attached reconciled list, including nonprescription products
Last-use times: recorded for the period requested
Differences: missed, new, stopped, or uncertain items clearly marked
Question: which item, if any, changes this test's instructions?
Keep the reply with the final report. If the laboratory later adds an interference comment, preserve its exact wording and ask what it means for the affected result. Do not turn a possibility into a diagnosis.
A well-built list does something simple and important: it replaces memory and assumptions with a shared factual record. That gives the people responsible for the test enough context to issue safe preparation instructions and to interpret the measurement without asking the patient to redesign treatment alone.
Sources
- MedlinePlus: How to Prepare for a Lab Test
People should disclose medicines, vitamins, and supplements during test preparation and should not stop a medicine unless their provider directs them.
- NIH Office of Dietary Supplements: My Dietary Supplement and Medicine Record
The NIH record provides fields for prescription, nonprescription, and supplement product names, amounts, schedules, start or stop dates, purpose, and responsible contact.
- FDA: Testing for Biotin Interference in In Vitro Diagnostic Devices
Biotin can interfere with some laboratory assay designs, and the direction and size of interference depend on the particular test system.